Liver toxicity after the introduction of highly active antiretroviral therapy

被引：0
|
作者：
Lana, R [1 ]
Mendoza, JL [1 ]
Núñez, M [1 ]
Soriano, V [1 ]
González-Lahoz, J [1 ]
机构：
[1] Inst Salud Carlos III, Madrid, Spain
来源：
AIDS | 2000年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P163
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [31] Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy
    Berenguer, Juan
    Miralles, Pilar
    Ribera, Jose Maria
    Rubio, Rafael
    Valencia, Eulalia
    Mahillo, Beatriz
    Pintado, Vicente
    Palacios, Rosario
    Montes, Maria Luisa
    Tellez, Maria Jesus
    La Cruz, Jose
    Torre-Cisneros, Julian
    Rodriguez-Arrondo, Francisco
    Sepulveda, Maria Antonia
    Gutierrez, Felix
    Peralta, Galo
    Boix, Vicente
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (04) : 422 - 428
  • [32] Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy - Reply
    Jacobson, MA
    [J]. LANCET, 1997, 350 (9077): : 590 - 590
  • [33] Opportunistic infections shortly after beginning highly active antiretroviral therapy
    Rodríguez-Rosado, R
    Soriano, V
    Dona, C
    González-Lahoz, J
    [J]. ANTIVIRAL THERAPY, 1998, 3 (04) : 229 - 231
  • [34] Clearance of cytomegalovirus viremia after initiation of highly active antiretroviral therapy
    Boivin, G
    LeBlanc, RP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03): : 1216 - 1217
  • [35] Immune function and phenotype before and after highly active antiretroviral therapy
    Sondergaard, SR
    Aladdin, H
    Ullum, H
    Gerstoft, J
    Skinhoj, P
    Pedersen, BK
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (05): : 376 - 383
  • [36] Remission of HIV myelopathy after highly active antiretroviral therapy - Reply
    Staudinger, R
    Henry, K
    [J]. NEUROLOGY, 2000, 55 (03) : 456 - 456
  • [37] Mortality and progression to AIDS after starting highly active antiretroviral therapy
    van Sighem, AI
    van de Wiel, MA
    Ghani, AC
    Jambroes, M
    Reiss, P
    Gyssens, IC
    Brinkman, K
    Lange, JMA
    de Wolf, F
    [J]. AIDS, 2003, 17 (15) : 2227 - 2236
  • [38] Salvage therapy and formulation of highly active antiretroviral therapy
    Fessel, WJ
    Follansbee, SE
    Young, TP
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 24 (02) : 194 - 195
  • [39] Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy
    Schmidt-Westhausen, AM
    Priepke, F
    Bergmann, FJ
    Reichart, PA
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2000, 29 (07) : 336 - 341
  • [40] Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy
    Deayton, JR
    Wilson, P
    Sabin, CA
    Davey, CC
    Johnson, MA
    Emery, VC
    Griffiths, PD
    [J]. AIDS, 2000, 14 (09) : 1163 - 1170
12345